Connect your AI

Evommune EVMN Revolving credit facility

Revolving credit facility at other companies

Dominion EnergyD

$0—

CarvanaCVNA

$79M+23.4%

MACOM Technology SolutionsMTSI

$7.19M—

HEICOHEI

$443M+206%

Labcorp HoldingsLH

$0-100%

Two Harbors Investment CorporationTWO

$916.87M-1.7%

Other financials

Income statement

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept us-gaap:LinesOfCreditCurrent.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's revolving credit facility.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Evommune 's revolving credit facility?: Evommune (EVMN) reported revolving credit facility of $8.11K in Q4 2025.